LLY

Eli Lilly and Company

78
Fundamentals85/ 100
Valuation62/ 100
Upside potential72/ 100
Risk potential15/ 100

LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.

SEER

Seer, Inc.

There isn't enough reported data to score SEER yet.

LLY Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.

SEER Fundamentals

MetricStatus
Under pressure
Under pressure
Weak
Unavailable

SEER's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.

LLY PE Valuation

CHEAPFAIREXPENSIVE37x74x111x147x
CHEAPFAIREXPENSIVE37x74x111x147x
LevelPEPriceVs current
Cheap27x$845-41%
Forward30x$1,427โ€”
Current46x$1,427โ€”
Fair48x$1,466+2.7%
Expensive85x$2,612+83%

Historical ranges are pointers, not guarantees.

LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.

SEER PE Valuation

SEER has no meaningful PE right now: it lost money over the past year.

LLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for LLY, with profitability improving.

SEER Forward outlook

MetricOutlook
--
Losses shrinking
Growth
--
Limited
Moderate

Analysts expect SEER's losses to shrink, with revenue growing.

LLY Risk to reward

ScenarioChangePrice
Upside+39%$1,988.49
Downside-15%$1,209.08

Calculated from the latest close: $1,427.28 on Nov 12.

There is not enough scenario data to compare LLY and SEER's risk to reward.

SEER Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.59 on Nov 12.

There is not enough scenario data to compare LLY and SEER's risk to reward.

LLY Earnings Per Share

Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
QuarterTTM EPSYoY
Forward$46.82+52%
Q3 2026$30.81+51%
Q2 2026$29.80+95%
Q1 2026$28.15+129%
Q4 2025$22.95+96%
Q3 2025$20.44+121%
Q2 2025$15.30+88%
Q1 2025$12.29+81%
Q4 2024$11.71+102%

LLY has the edge over SEER on earnings quality, reporting a profit while its opponent remains loss making.

SEER Earnings Per Share

Q4 2023: $-1.35Q1 2024: $-1.29Q2 2024: $-1.27Q3 2024: $-1.29Q4 2024: $-1.39Q1 2025: $-1.41Q2 2025: $-1.39Q3 2025: $-1.36Q4 2025: $-1.28Q1 2026: $-1.24Q2 2026: $-1.22Q3 2026: $-1.15
Q4 2023: $-1.35Q1 2024: $-1.29Q2 2024: $-1.27Q3 2024: $-1.29Q4 2024: $-1.39Q1 2025: $-1.41Q2 2025: $-1.39Q3 2025: $-1.36Q4 2025: $-1.28Q1 2026: $-1.24Q2 2026: $-1.22Q3 2026: $-1.15
QuarterTTM EPSYoY
Q3 2026-$1.15+$0.21
Q2 2026-$1.22+$0.17
Q1 2026-$1.24+$0.17
Q4 2025-$1.28+$0.11
Q3 2025-$1.36-$0.07
Q2 2025-$1.39-$0.12
Q1 2025-$1.41-$0.12
Q4 2024-$1.39-$0.04

SEER is still losing money, but less than at its worst: $1.15 per share over the past year, against $1.49 at its worst in late 2022.

LLY Quarterly Revenue

Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
QuarterRevenueYoY
Q3 2026$24.4B+39%
Q2 2026$23B+48%
Q1 2026$19.8B+56%
Q4 2025$19.3B+43%
Q3 2025$17.6B+54%
Q2 2025$15.6B+38%
Q1 2025$12.7B+45%
Q4 2024$13.5B+45%

LLY has the edge over SEER on sales, with more consistent year-over-year improvement.

SEER Quarterly Revenue

Q4 2023: $4MQ1 2024: $3MQ2 2024: $3MQ3 2024: $4MQ4 2024: $4MQ1 2025: $4MQ2 2025: $4MQ3 2025: $4MQ4 2025: $4MQ1 2026: $3MQ2 2026: $3MQ3 2026: $4M
Q4 2023: $4MQ1 2024: $3MQ2 2024: $3MQ3 2024: $4MQ4 2024: $4MQ1 2025: $4MQ2 2025: $4MQ3 2025: $4MQ4 2025: $4MQ1 2026: $3MQ2 2026: $3MQ3 2026: $4M
QuarterRevenueYoY
Q3 2026$4M+0.3%
Q2 2026$3.1M-21%
Q1 2026$2.8M-33%
Q4 2025$4.2M+5%
Q3 2025$4M-1.6%
Q2 2025$3.9M+28%
Q1 2025$4.1M+35%
Q4 2024$4M-9.9%

SEER's revenue is down over the past year, though its latest quarter was up: $4M last quarter, about level with the same quarter a year ago.

LLY Free Cash Flow

Q4 2023: โˆ’$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
Q4 2023: โˆ’$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
QuarterFree cash flowYoY
Q3 2026$8.2B+22%
Q2 2026$7.8B+458%
Q1 2026$3B+1826%
Q4 2025$677.9M-31%
Q3 2025$6.7B+186%
Q2 2025$1.4B+476%
Q1 2025$156.1M-13%
Q4 2024$977.8M+$2.4B

LLY has the edge over SEER on cash generation, producing positive trailing cash flow while its opponent burns cash.

SEER Free Cash Flow

Q4 2023: โˆ’$12MQ1 2024: โˆ’$11MQ2 2024: โˆ’$11MQ3 2024: โˆ’$16MQ4 2024: โˆ’$11MQ1 2025: โˆ’$12MQ2 2025: โˆ’$15MQ3 2025: โˆ’$8MQ4 2025: โˆ’$11MQ1 2026: โˆ’$16MQ2 2026: โˆ’$10MQ3 2026: โˆ’$10M
Q4 2023: โˆ’$12MQ1 2024: โˆ’$11MQ2 2024: โˆ’$11MQ3 2024: โˆ’$16MQ4 2024: โˆ’$11MQ1 2025: โˆ’$12MQ2 2025: โˆ’$15MQ3 2025: โˆ’$8MQ4 2025: โˆ’$11MQ1 2026: โˆ’$16MQ2 2026: โˆ’$10MQ3 2026: โˆ’$10M
QuarterFree cash flowYoY
Q3 2026-$10M-$2.1M
Q2 2026-$9.6M+$5.6M
Q1 2026-$15.7M-$3.6M
Q4 2025-$11.1M-$178K
Q3 2025-$7.8M+$8.5M
Q2 2025-$15.2M-$4M
Q1 2025-$12.1M-$861K
Q4 2024-$10.9M+$1.1M

SEER has burned cash in almost every quarter: โˆ’$46M over the past year, against โˆ’$46M the year before.

LLY Total Shares

Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
PeriodChange %Net change
Quarterly0%-300K shares
1 year-0.6%-5.4M shares
3 years-0.7%-6.4M shares
5 years-1.9%-17.4M shares
Available history-4.5%-42.3M shares

LLY has 893M diluted shares, down 0.6% from a year ago.

SEER Total Shares

Q4 2023: 64MQ1 2024: 65MQ2 2024: 65MQ3 2024: 61MQ4 2024: 60MQ1 2025: 59MQ2 2025: 58MQ3 2025: 56MQ4 2025: 56MQ1 2026: 55MQ2 2026: 55MQ3 2026: 56M
Q4 2023: 64MQ1 2024: 65MQ2 2024: 65MQ3 2024: 61MQ4 2024: 60MQ1 2025: 59MQ2 2025: 58MQ3 2025: 56MQ4 2025: 56MQ1 2026: 55MQ2 2026: 55MQ3 2026: 56M
PeriodChange %Net change
Quarterly+0.8%+443K shares
1 year-0.9%-498K shares
3 years-13%-8.1M shares
5 years-8.7%-5.3M shares
Available history+58%+20.4M shares

SEER has the edge over LLY on shareholder dilution, with a more favorable share count trend.

LLY Net Leverage

Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
QuarterNet LeverageStatus
Q3 20261.2xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.3xHealthy
Q3 20251.3xHealthy
Q2 20252.0xHealthy
Q1 20252.3xModerate
Q4 20242.1xModerate

LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.

SEER Net Leverage

SEER's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LLY Weekly Momentum

MetricValueStatus
RSI68.3Neutral
Stochastic84.1Overbought

LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).

SEER Weekly Momentum

MetricValueStatus
RSI38.7Neutral
Stochastic4.7Oversold

SEER's weekly RSI is 39 (neutral) and its Stochastic is 5 (oversold).

LLY PE vs Healthcare Sector

MetricLLYSector medianRelative
PE46x26x79% above
PE %482919 pts above

LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.

SEER PE vs Healthcare Sector

SEER has no meaningful PE right now: it lost money over the past year.

LLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,279.412% above
20 week MA$1,218.817% above
50 week MA$1,102.229% above
100 week MA$954.150% above
200 week MA$797.579% above

LLY has the edge over SEER on trend strength, trading above more of its moving averages.

SEER Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.9117% below
20 week MA$1.9719% below
50 week MA$1.8815% below
100 week MA$2.0020% below
200 week MA$2.3231% below

SEER is in a downtrend: it's below all five of its weekly moving averages, and 31% below its 200-week average.

LLY Yearly ROI

YearStart priceEnd priceROI
2020$131.5$166.7+27%
2021$166.7$273.1+64%
2022$273.1$367.9+35%
2023$367.9$582.9+58%
2024$582.9$783.2+34%
2025$783.2$1,077.8+38%
2026 YTD$1,077.8$1,427.3+32%

LLY has the edge over SEER on returns for 2026, with the stronger performance.

SEER Yearly ROI

YearStart priceEnd priceROI
2020$56.5$62.0+9.9%
2021$62.0$23.8-62%
2022$23.8$5.65-76%
2023$5.65$1.94-66%
2024$1.94$2.26+16%
2025$2.26$1.84-19%
2026 YTD$1.84$1.59-14%

SEER has finished lower in four of the last six years. It's down 14% so far in 2026.

Give your agent the market.

Get API key